Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
434 questions in 75 reviews · Metabolic and Endocrine Disorders
current versionsNo studies 434 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Microvascular outcomes · participants with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality · participants with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cardiovascular mortality · participants with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Macrovascular outcomes · participants with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Microvascular outcomes · participants with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cancer · participants with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · participants with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Microvascular outcomes · participants with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · participants with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Ipomoea batatas (Caiapo) tablets vs placebo Morbidity · people with type 2 diabetes mellitus Sweet potato for type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Ipomoea batatas (Caiapo) tablets vs placebo Health‐related quality of life · people with type 2 diabetes mellitus Sweet potato for type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Ipomoea batatas (Caiapo) tablets vs placebo Well‐being · people with type 2 diabetes mellitus Sweet potato for type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Ipomoea batatas (Caiapo) tablets vs placebo Functional outcomes · people with type 2 diabetes mellitus Sweet potato for type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Ipomoea batatas (Caiapo) tablets vs placebo Costs · people with type 2 diabetes mellitus Sweet potato for type 2 diabetes mellitus (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cardiovascular events · postmenopausal women with hypercholesterolaemia Isoflavones for hypercholesterolaemia in adults (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Death from any cause · postmenopausal women with hypercholesterolaemia Isoflavones for hypercholesterolaemia in adults (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · postmenopausal women with hypercholesterolaemia Isoflavones for hypercholesterolaemia in adults (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs · postmenopausal women with hypercholesterolaemia Isoflavones for hypercholesterolaemia in adults (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Death from any cause · participants with hypertriglyceridaemia Chinese herbal medicines for hypertriglyceridaemia (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cardiovascular or cerebrovascular events · participants with hypertriglyceridaemia Chinese herbal medicines for hypertriglyceridaemia (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events [ · participants with hypertriglyceridaemia Chinese herbal medicines for hypertriglyceridaemia (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · participants with hypertriglyceridaemia Chinese herbal medicines for hypertriglyceridaemia (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs · participants with hypertriglyceridaemia Chinese herbal medicines for hypertriglyceridaemia (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · overweight or obese adults Chromium picolinate supplementation for overweight or obese adults (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Death from any cause · overweight or obese adults Chromium picolinate supplementation for overweight or obese adults (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Morbidity · overweight or obese adults Chromium picolinate supplementation for overweight or obese adults (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects · overweight or obese adults Chromium picolinate supplementation for overweight or obese adults (2013) · Cochrane | no estimate extracted | NR | No studies |
Selenium (+LT4) vs placebo (+LT4) Change from baseline in health‐related quality of life · participants with Hashimoto's thyroiditis. Selenium supplementation for Hashimoto's thyroiditis (2013) · Cochrane | no estimate extracted | NR | No studies |
Selenium (+LT4) vs placebo (+LT4) Change from baseline in LT4 replacement dosage at end of study · participants with Hashimoto's thyroiditis. Selenium supplementation for Hashimoto's thyroiditis (2013) · Cochrane | no estimate extracted | NR | No studies |
Selenium (+LT4) vs placebo (+LT4) Economic costs · participants with Hashimoto's thyroiditis. Selenium supplementation for Hashimoto's thyroiditis (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Morbidity · Patients with type 2 diabetes mellitus Self‐monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · patients with type 2 diabetes mellitus Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2… (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects · patients with type 2 diabetes mellitus Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2… (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs · patients with type 2 diabetes mellitus Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2… (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Death from any cause ( · patients with diabetes mellitus Cinnamon for diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Morbidity ( · patients with diabetes mellitus Cinnamon for diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life ( · patients with diabetes mellitus Cinnamon for diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs ( · patients with diabetes mellitus Cinnamon for diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Interactive computer intervention vs usual care Health‐related quality of life · adults with overweight or obesity Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people (2012) · Cochrane | no estimate extracted | NR | No studies |
Interactive computer intervention vs in‐person interventions Physical‐activity related outcomes · adults with overweight or obesity Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people (2012) · Cochrane | no estimate extracted | NR | No studies |
Interactive computer intervention vs usual care Adverse effects · adults with overweight or obesity Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people (2012) · Cochrane | no estimate extracted | NR | No studies |
Interactive computer intervention vs usual care Physical‐activity related outcomes · adults with overweight or obesity Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people (2012) · Cochrane | no estimate extracted | NR | No studies |
Interactive computer intervention vs usual care Cost‐effectiveness · adults with overweight or obesity Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people (2012) · Cochrane | no estimate extracted | NR | No studies |
Interactive computer intervention vs in‐person interventions Health‐related quality of life · adults with overweight or obesity Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people (2012) · Cochrane | no estimate extracted | NR | No studies |
Interactive computer intervention vs in‐person interventions Adverse effects · adults with overweight or obesity Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Death from any cause · Patients with type 2 diabetes mellitus Momordica charantia for type 2 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Morbidity · Patients with type 2 diabetes mellitus Momordica charantia for type 2 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · Patients with type 2 diabetes mellitus Momordica charantia for type 2 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs · Patients with type 2 diabetes mellitus Momordica charantia for type 2 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Diabetic complications · patients with type 1 diabetes mellitus Continuous glucose monitoring systems for type 1 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |